Alaina Vidmar, MD is an Assistant Professor in Pediatric Endocrinology at Children’s Hospital Los Angeles. Dr. Vidmar received her medical degree and completed her residency in Pediatrics at the Children's Hospital of Wisconsin. She completed her fellowship in Pediatric Endocrinology at the Children's Hospital of Los Angeles.
Dr. Vidmar’s main research and clinical interest is improving patient outcomes through novel clinical approaches and behavioral interventions for youth with overweight and obesity. Dr. Vidmar is interested in utilizing mobile health interventions to increase the reach of clinical and behavioral interventions for pediatric obesity management. Her current work is examining the use an addiction-based weight loss intervention, in the form of an iPhone app, as a method to promote sustained weight loss in adolescents. Dr. Vidmar currently has funding from eHealth Incorporated to investigate the cost efficacy of mobile health interventions compared to traditional multi-disciplinary in clinic models for pediatric obesity management.
Medical College of Wisconsin
Children's Hospital of Wisconsin, Pediatric Internship
Children's Hospital of Wisconsin, Pediatric Residency
Children's Hospital of Los Angeles, Pediatric Endocrinology Fellowship
American Board of Pediatrics
The Obesity Society
Foundation for Prader-Willi Research
Pediatric Endocrine Society
The Endocrine Society
The American Diabetes Association
Vidmar, AP., Pretlow, R., Borzutzky, C., Wee, CP., Fox, DS., Fink, C., Mittelman, DS. An Addiction Model Based Mobile Health Weight Loss Intervention in Obese Adolescents. Pediatric Obesity. 2018; 24:1-7.
Vidmar AP, Weber J, Koppin C, Monzavi R, Kim MS. Improved Medical-Alert ID Utilization Following a Parent Educational Intervention. Journal of Pediatric Endocrinology and Metabolism. 2018; 31(2):213-219
Vidmar, AP., Miyazaki B., Sanchez-Lara PA., Pitukcheewanont, P. X-Linked Hypophosphatemic Rickets, del(2)(q37.1;q37.3) Deletion Syndrome and Mosaic Turner Syndrome, mos 45,X/46,X, del(2)(q37.1;q37.3) in a 3-year-old Female. Journal of Bone Metabolism 2017; 24:1-7.
Vidmar, AP., Ng, C., Ganster, A., and Pitukcheewanont, P. Asfotase Alfa Treatment of an African-American Infant with Perinatal Hypophosphatasia and Homozygous Hemoglobin SC Disease. BoneKEys 2017;849:1-4.
Wongsaengsak,S., Vidmar, AP., Addala, A., Kamil, E.S., Sequeira, P., Fass, B., Pitukcheewanont, P.
A novel SLC12A1 Gene Mutation Associated with Hyperparathyroidism, Hypercalcemia, Nephrogenic Diabetes Insipidus, and Nephrocalcinosis in Four Patients. BONE 2017;97:121-125.